The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Irreversible Electroporation Ablators-Global Market Insights and Sales Trends 2025
Synopsis
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
The global Irreversible Electroporation Ablators market size is expected to reach US$ 48 million by 2029, growing at a CAGR of 9.1% from 2023 to 2029. The market is mainly driven by the significant applications of Irreversible Electroporation Ablators in various end use industries. The expanding demands from the Liver, Pancreas, Prostate and Others, are propelling Irreversible Electroporation Ablators market. Generator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Part segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irreversible Electroporation Ablators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irreversible Electroporation Ablators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irreversible Electroporation Ablators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irreversible Electroporation Ablators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irreversible Electroporation Ablators covered in this report include AngioDynamics and Pulse Biosciences etc.
The global Irreversible Electroporation Ablators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AngioDynamics
Pulse Biosciences
Global Irreversible Electroporation Ablators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irreversible Electroporation Ablators market, Segment by Type:
Generator
Part
Service
Global Irreversible Electroporation Ablators market, by Application
Liver
Pancreas
Prostate
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Irreversible Electroporation Ablators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Irreversible Electroporation Ablators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
The global Irreversible Electroporation Ablators market size is expected to reach US$ 48 million by 2029, growing at a CAGR of 9.1% from 2023 to 2029. The market is mainly driven by the significant applications of Irreversible Electroporation Ablators in various end use industries. The expanding demands from the Liver, Pancreas, Prostate and Others, are propelling Irreversible Electroporation Ablators market. Generator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Part segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irreversible Electroporation Ablators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irreversible Electroporation Ablators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irreversible Electroporation Ablators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irreversible Electroporation Ablators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irreversible Electroporation Ablators covered in this report include AngioDynamics and Pulse Biosciences etc.
The global Irreversible Electroporation Ablators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AngioDynamics
Pulse Biosciences
Global Irreversible Electroporation Ablators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irreversible Electroporation Ablators market, Segment by Type:
Generator
Part
Service
Global Irreversible Electroporation Ablators market, by Application
Liver
Pancreas
Prostate
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Irreversible Electroporation Ablators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Irreversible Electroporation Ablators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Irreversible Electroporation Ablators Market Overview
1.1 Irreversible Electroporation Ablators Product Overview
1.2 Irreversible Electroporation Ablators Market Segment by Type
1.2.1 Generator
1.2.2 Part
1.2.3 Service
1.3 Global Irreversible Electroporation Ablators Market Size by Type
1.3.1 Global Irreversible Electroporation Ablators Market Size Overview by Type (2018-2029)
1.3.2 Global Irreversible Electroporation Ablators Historic Market Size Review by Type (2018-2023)
1.3.3 Global Irreversible Electroporation Ablators Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Irreversible Electroporation Ablators Sales Breakdown by Type (2018-2023)
1.4.2 Europe Irreversible Electroporation Ablators Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Irreversible Electroporation Ablators Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Irreversible Electroporation Ablators Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Irreversible Electroporation Ablators Sales Breakdown by Type (2018-2023)
2 Global Irreversible Electroporation Ablators Market Competition by Company
2.1 Global Top Players by Irreversible Electroporation Ablators Sales (2018-2023)
2.2 Global Top Players by Irreversible Electroporation Ablators Revenue (2018-2023)
2.3 Global Top Players by Irreversible Electroporation Ablators Price (2018-2023)
2.4 Global Top Manufacturers Irreversible Electroporation Ablators Manufacturing Base Distribution, Sales Area, Product Type
2.5 Irreversible Electroporation Ablators Market Competitive Situation and Trends
2.5.1 Irreversible Electroporation Ablators Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Irreversible Electroporation Ablators Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irreversible Electroporation Ablators as of 2022)
2.7 Date of Key Manufacturers Enter into Irreversible Electroporation Ablators Market
2.8 Key Manufacturers Irreversible Electroporation Ablators Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Irreversible Electroporation Ablators Status and Outlook by Region
3.1 Global Irreversible Electroporation Ablators Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Irreversible Electroporation Ablators Historic Market Size by Region
3.2.1 Global Irreversible Electroporation Ablators Sales in Volume by Region (2018-2023)
3.2.2 Global Irreversible Electroporation Ablators Sales in Value by Region (2018-2023)
3.2.3 Global Irreversible Electroporation Ablators Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Irreversible Electroporation Ablators Forecasted Market Size by Region
3.3.1 Global Irreversible Electroporation Ablators Sales in Volume by Region (2024-2029)
3.3.2 Global Irreversible Electroporation Ablators Sales in Value by Region (2024-2029)
3.3.3 Global Irreversible Electroporation Ablators Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Irreversible Electroporation Ablators by Application
4.1 Irreversible Electroporation Ablators Market Segment by Application
4.1.1 Liver
4.1.2 Pancreas
4.1.3 Prostate
4.1.4 Others
4.2 Global Irreversible Electroporation Ablators Market Size by Application
4.2.1 Global Irreversible Electroporation Ablators Market Size Overview by Application (2018-2029)
4.2.2 Global Irreversible Electroporation Ablators Historic Market Size Review by Application (2018-2023)
4.2.3 Global Irreversible Electroporation Ablators Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Irreversible Electroporation Ablators Sales Breakdown by Application (2018-2023)
4.3.2 Europe Irreversible Electroporation Ablators Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Irreversible Electroporation Ablators Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Irreversible Electroporation Ablators Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Irreversible Electroporation Ablators Sales Breakdown by Application (2018-2023)
5 North America Irreversible Electroporation Ablators by Country
5.1 North America Irreversible Electroporation Ablators Historic Market Size by Country
5.1.1 North America Irreversible Electroporation Ablators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Irreversible Electroporation Ablators Sales in Volume by Country (2018-2023)
5.1.3 North America Irreversible Electroporation Ablators Sales in Value by Country (2018-2023)
5.2 North America Irreversible Electroporation Ablators Forecasted Market Size by Country
5.2.1 North America Irreversible Electroporation Ablators Sales in Volume by Country (2024-2029)
5.2.2 North America Irreversible Electroporation Ablators Sales in Value by Country (2024-2029)
6 Europe Irreversible Electroporation Ablators by Country
6.1 Europe Irreversible Electroporation Ablators Historic Market Size by Country
6.1.1 Europe Irreversible Electroporation Ablators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Irreversible Electroporation Ablators Sales in Volume by Country (2018-2023)
6.1.3 Europe Irreversible Electroporation Ablators Sales in Value by Country (2018-2023)
6.2 Europe Irreversible Electroporation Ablators Forecasted Market Size by Country
6.2.1 Europe Irreversible Electroporation Ablators Sales in Volume by Country (2024-2029)
6.2.2 Europe Irreversible Electroporation Ablators Sales in Value by Country (2024-2029)
7 Asia-Pacific Irreversible Electroporation Ablators by Region
7.1 Asia-Pacific Irreversible Electroporation Ablators Historic Market Size by Region
7.1.1 Asia-Pacific Irreversible Electroporation Ablators Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Irreversible Electroporation Ablators Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Irreversible Electroporation Ablators Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Irreversible Electroporation Ablators Forecasted Market Size by Region
7.2.1 Asia-Pacific Irreversible Electroporation Ablators Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Irreversible Electroporation Ablators Sales in Value by Region (2024-2029)
8 Latin America Irreversible Electroporation Ablators by Country
8.1 Latin America Irreversible Electroporation Ablators Historic Market Size by Country
8.1.1 Latin America Irreversible Electroporation Ablators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Irreversible Electroporation Ablators Sales in Volume by Country (2018-2023)
8.1.3 Latin America Irreversible Electroporation Ablators Sales in Value by Country (2018-2023)
8.2 Latin America Irreversible Electroporation Ablators Forecasted Market Size by Country
8.2.1 Latin America Irreversible Electroporation Ablators Sales in Volume by Country (2024-2029)
8.2.2 Latin America Irreversible Electroporation Ablators Sales in Value by Country (2024-2029)
9 Middle East and Africa Irreversible Electroporation Ablators by Country
9.1 Middle East and Africa Irreversible Electroporation Ablators Historic Market Size by Country
9.1.1 Middle East and Africa Irreversible Electroporation Ablators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Irreversible Electroporation Ablators Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Irreversible Electroporation Ablators Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Irreversible Electroporation Ablators Forecasted Market Size by Country
9.2.1 Middle East and Africa Irreversible Electroporation Ablators Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Irreversible Electroporation Ablators Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AngioDynamics
10.1.1 AngioDynamics Company Information
10.1.2 AngioDynamics Introduction and Business Overview
10.1.3 AngioDynamics Irreversible Electroporation Ablators Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AngioDynamics Irreversible Electroporation Ablators Products Offered
10.1.5 AngioDynamics Recent Development
10.2 Pulse Biosciences
10.2.1 Pulse Biosciences Company Information
10.2.2 Pulse Biosciences Introduction and Business Overview
10.2.3 Pulse Biosciences Irreversible Electroporation Ablators Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pulse Biosciences Irreversible Electroporation Ablators Products Offered
10.2.5 Pulse Biosciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Irreversible Electroporation Ablators Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Irreversible Electroporation Ablators Industrial Chain Analysis
11.4 Irreversible Electroporation Ablators Market Dynamics
11.4.1 Irreversible Electroporation Ablators Industry Trends
11.4.2 Irreversible Electroporation Ablators Market Drivers
11.4.3 Irreversible Electroporation Ablators Market Challenges
11.4.4 Irreversible Electroporation Ablators Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Irreversible Electroporation Ablators Distributors
12.3 Irreversible Electroporation Ablators Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
